Touchon Pascal
President And CEO
1 company
Insider Signal Score
82
ExcellentTrades Analyzed
18
12M Win Rate
94.4%
Avg 3M Return
+10.3%
Avg 12M Return
+56.1%
Touchon Pascal is a President And CEO at Atara Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $870K based on current market prices.
Holdings by Company
ATRAJun 10, 2025
Current Shares78.0K
Value$870.0K
Net Activity-356,529
Bought: 0Sold: 356.5K
Transaction History
Showing 10 filings (page 2)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2022 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 14,220 | $7.20 | $102,384.00 | -2.9% | -51.8% | -75.7% | |
| May 17, 2022 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 13,913 | $5.32 | $73,961.51 | -2.8% | -4.5% | -63.1% | |
| Mar 1, 2022 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 8,828 | $9.86 | $87,008.77 | -1.7% | -49.1% | -61.7% | |
| Nov 16, 2021 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 8,402 | $17.12 | $143,816.19 | -2.5% | -18.0% | -73.7% | |
| Aug 17, 2021 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 8,223 | $12.53 | $103,050.64 | -2.4% | +34.5% | -62.8% | |
| Jun 25, 2021 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 14,194 | $16.32 | $231,660.27 | -4.0% | +5.8% | -55.3% | |
| May 18, 2021 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 8,313 | $14.55 | $120,954.15 | -2.3% | -14.6% | -64.7% | |
| Mar 2, 2021 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 4,887 | $16.74 | $81,808.38 | -1.3% | -17.5% | -42.1% | |
| Nov 17, 2020 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 4,716 | $19.77 | $93,254.18 | -1.8% | - | - | |
| Aug 18, 2020 | ATRA Atara Biotherapeutics, Inc. | President And CEO | Sell | 4,807 | $12.09 | $58,116.63 | -1.8% | - | - |